The new data bolster Allogene’s efforts to develop a new, easily administered cell therapy that could delay or prevent cancer recurrence.

ZFTA–RELA is the cancer-promoting protein product of a gene fusion. Analyses of accessible sites in the DNA–protein complex chromatin in developing mice show that ZFTA–RELA binds to chromatin modules ...

Researchers at Umeå University have contributed new insights into how cancer cells protect themselves from cell death. The ...

Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible ...

Scientists in Canada have uncovered a surprising weakness in glioblastoma, one of the deadliest brain cancers. They found ...

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...

Trudy Oliver, professor of pharmacology and cancer biology, is part of a team of scientists that recently published a study uncovering a major shift in how scientists understand small-cell lung cancer ...

A new study led by researchers at the University of Liège highlights the unexpected role of Stard7 in the development of intestinal cancers.

Researchers found that pancreatic pre-cancer cells mimic dementia by forming clumps of proteins due to faulty recycling processes. These insights could shed light on why pancreatic cancer develops so ...

Trastuzumab pamirtecan, being developed under a 2023 partnership between BioNTech and DualityBio, elicited a 44.1% overall ...